Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus

Horm Metab Res. 1992 Nov;24(11):516-9. doi: 10.1055/s-2007-1003378.

Abstract

The fibrinolytic system was investigated in 38 patients (21 males and 17 females) affected by type 1 diabetes mellitus (18 free from complications, 10 with retinopathy, and 10 with autonomic neuropathy) and in 8 healthy controls. Two separate fibrinolysis-stimulating tests were done: standardized venous occlusion and 1-desamino-8-D-arginine vasopressin infusion. Plasma tissue plasminogen activator antigen and activity and plasma plasminogen activator inhibitor activity were measured. All the patients were in good metabolic control (mean HbA1c 7.4%, range 6.1-8.0%). No significant differences were observed either between the diabetic patients and the control subjects, nor among the subgroups of diabetic patients. The fibrinolytic system is probably not involved in type 1 diabetes mellitus.

MeSH terms

  • Deamino Arginine Vasopressin / pharmacology
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetic Neuropathies / blood
  • Diabetic Retinopathy / blood
  • Female
  • Fibrinolysis
  • Humans
  • Male
  • Plasminogen Activator Inhibitor 1 / blood*
  • Tissue Plasminogen Activator / blood*

Substances

  • Plasminogen Activator Inhibitor 1
  • Tissue Plasminogen Activator
  • Deamino Arginine Vasopressin